The Application of Genome-Wide 5-Hydroxymethylcytosine Studies in Cancer Research

References

• Feinberg AP , KoldobskiyMA , GondorA . Epigenetic modulators, modifiers and mediators in cancer aetiology and progression . Nat. Rev. Genet.17 ( 5 ), 284 – 299 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Liu F , WangL , PernaF , NimerSD . Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape . Nat. Rev. Cancer16 ( 6 ), 359 – 372 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Fang M , OuJ , HutchinsonL , GreenMR . The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype . Mol. Cell55 ( 6 ), 904 – 915 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Serra RW , FangM , ParkSM , HutchinsonL , GreenMR . A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype . Elife3 , e02313 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Shah MA , DentonEL , ArrowsmithCH , LupienM , SchapiraM . A global assessment of cancer genomic alterations in epigenetic mechanisms . Epigenetics Chromatin7 ( 1 ), 29 ( 2014 ).
   PubMedGoogle Scholar
• Yang Z , JonesA , WidschwendterM , TeschendorffAE . An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer . Genome Biol.16 , 140 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Dalgliesh GL , FurgeK , GreenmanCet al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes . Nature463 ( 7279 ), 360 – 363 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA . Hallmarks of cancer: the next generation . Cell144 ( 5 ), 646 – 674 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Timp W , FeinbergAP . Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host . Nat. Rev. Cancer13 ( 7 ), 497 – 510 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sproul D , MeehanRR . Genomic insights into cancer-associated aberrant CpG island hypermethylation . Brief Funct. Genomics12 ( 3 ), 174 – 190 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Forbes SA , BindalN , BamfordSet al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer . Nucleic Acids Res.39 , D945 – D950 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bird A . DNA methylation patterns and epigenetic memory . Genes Dev.16 ( 1 ), 6 – 21 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Dunican DS , CruickshanksHA , SuzukiMet al. Lsh regulates LTR retrotransposon repression independently of Dnmt3b function . Genome Biol.14 ( 12 ), R146 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hackett JA , ReddingtonJP , NestorCEet al. Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline . Development139 ( 19 ), 3623 – 3632 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tahiliani M , KohKP , ShenYet al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 . Science324 ( 5929 ), 930 – 935 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Thomson JP , HunterJM , MeehanRR . Deep C diving: mapping the low-abundance modifications of the DNA demethylation pathway . Genome Biol.14 ( 5 ), 118 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bachman M , Uribe-LewisS , YangX , WilliamsM , MurrellA , BalasubramanianS . 5-Hydroxymethylcytosine is a predominantly stable DNA modification . Nat. Chem.6 ( 12 ), 1049 – 1055 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• He YF , LiBZ , LiZet al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA . Science333 ( 6047 ), 1303 – 1307 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Xu X , WattDS , LiuC . Multifaceted roles for thymine DNA glycosylase in embryonic development and human carcinogenesis . Acta Biochim. Biophys. Sin.48 ( 1 ), 82 – 89 ( 2016 ).
   Google Scholar
• Guo F , LiX , LiangDet al. Active and passive demethylation of male and female pronuclear DNA in the mammalian zygote . Cell Stem Cell15 ( 4 ), 447 – 458 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Xu G-L , WongJ . Oxidative DNA demethylation mediated by Tet enzymes . Natl Sci. Rev.2 , 318 – 328 ( 2015 ).
   Web of Science ®Google Scholar
• Goodwin S , McphersonJD , MccombieWR . Coming of age: ten years of next-generation sequencing technologies . Nat. Rev. Genet.17 ( 6 ), 333 – 351 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Nik-Zainal S , DaviesH , StaafJet al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences . Nature534 ( 7605 ), 47 – 54 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Gu L , FrommelSC , OakesCCet al. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence . Nat. Genet.47 ( 1 ), 22 – 30 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kriaucionis S , HeintzN . The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain . Science324 ( 5929 ), 929 – 930 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ficz G , GribbenJG . Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?Genomics104 ( 5 ), 352 – 357 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Neri F , DettoriD , IncarnatoDet al. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway . Oncogene34 ( 32 ), 4168 – 4176 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ichimura N , ShinjoK , AnBet al. Aberrant TET1 methylation closely associated with CpG island methylator phenotype in colorectal cancer . Cancer Prev. Res. (Phila.)8 ( 8 ), 702 – 711 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Wu BK , BrennerC . Suppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation . Cell Rep.9 ( 5 ), 1827 – 1840 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Thienpont B , SteinbacherJ , ZhaoHet al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity . Nature537 ( 7618 ), 63 – 68 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Laird A , ThomsonJP , HarrisonDJ , MeehanRR . 5-hydroxymethylcytosine profiling as an indicator of cellular state . Epigenomics5 ( 6 ), 655 – 669 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Shen L , WuH , DiepDet al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics . Cell153 ( 3 ), 692 – 706 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nestor CE , OttavianoR , ReddingtonJet al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes . Genome Res.22 ( 3 ), 467 – 477 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Song CX , YiC , HeC . Mapping recently identified nucleotide variants in the genome and transcriptome . Nat. Biotechnol.30 ( 11 ), 1107 – 1116 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Thomson JP , HunterJM , NestorCEet al. Comparative analysis of affinity-based 5-hydroxymethylation enrichment techniques . Nucleic Acids Res.41 ( 22 ), e206 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bogdanovic O , SmitsAH , De La Calle MustienesEet al. Active DNA demethylation at enhancers during the vertebrate phylotypic period . Nat. Genet.48 ( 4 ), 417 – 426 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Li X , LiuY , SalzT , HansenKD , FeinbergAP . Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver . Genome Res.26 , 1730 – 1741 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Nestor CE , LentiniA , Hägg-NilssonCet al. 5-hydroxymethylcytosine remodeling precedes lineage specification during differentiation of human CD4+ T-cells . Cell Reports16 ( 2 ), 559 – 570 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Neri F , IncarnatoD , KrepelovaAet al. Single-base resolution analysis of 5-formyl and 5-carboxyl cytosine reveals promoter DNA methylation dynamics . Cell Rep.10 , 674 – 683 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sproul D , KitchenRR , NestorCEet al. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns . Genome Biol.13 ( 10 ), R84 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Feinberg AP , OhlssonR , HenikoffS . The epigenetic progenitor origin of human cancer . Nat. Rev. Genet.7 ( 1 ), 21 – 33 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Baylin SB , JonesPA . A decade of exploring the cancer epigenome – biological and translational implications . Nat. Rev. Cancer11 ( 10 ), 726 – 734 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Irizarry RA , Ladd-AcostaC , WenBet al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores . Nat. Genet.41 ( 2 ), 178 – 186 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bell RE , GolanT , SheinboimDet al. Enhancer methylation dynamics contribute to cancer plasticity and patient mortality . Genome Res.26 ( 5 ), 601 – 611 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Gao F , XiaY , WangJet al. Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma . Genome Biol.15 ( 12 ), 533 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Figueroa ME , Abdel-WahabO , LuCet al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation . Cancer Cell18 ( 6 ), 553 – 567 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Rampal R , AlkalinA , MadzoJet al. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia . Cell Rep.9 ( 5 ), 1841 – 1855 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Thomson JP , OttavianoR , UnterbergerEBet al. Loss of Tet1-associated 5-hydroxymethylcytosine is concomitant with aberrant promoter hypermethylation in liver cancer . Cancer Res.76 ( 10 ), 3097 – 3108 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Gambichler T , SandM , SkryganM . Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma . Melanoma Res.23 ( 3 ), 218 – 220 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Jin SG , JiangY , QiuRet al. 5-hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations . Cancer Res.71 ( 24 ), 7360 – 7365 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kudo Y , TateishiK , YamamotoKet al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation . Cancer Sci.103 ( 4 ), 670 – 676 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Orr BA , HaffnerMC , NelsonWG , YegnasubramanianS , EberhartCG . Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma . PLoS ONE7 ( 7 ), e41036 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Liu C , LiuL , ChenXet al. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1 . PLoS ONE8 ( 5 ), e62828 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Park JL , KimHJ , SeoEHet al. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3′-shore . Oncotarget6 ( 35 ), 37647 – 37662 ( 2015 ).
   PubMedGoogle Scholar
• Chen K , ZhangJ , GuoZet al. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer . Cell Res.26 ( 1 ), 103 – 118 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kroeze LI , AslanyanMG , Van RooijAet al. Characterization of acute myeloid leukemia based on levels of global hydroxymethylation . Blood124 ( 7 ), 1110 – 1118 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lian CG , XuY , CeolCet al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma . Cell150 ( 6 ), 1135 – 1146 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rasmussen KD , HelinK . Role of TET enzymes in DNA methylation, development, and cancer . Genes Dev.30 ( 7 ), 733 – 750 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Dawlaty MM , GanzK , PowellBEet al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development . Cell Stem Cell9 ( 2 ), 166 – 175 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Putiri EL , TiedemannRL , ThompsonJJet al. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells . Genome Biol.15 ( 6 ), R81 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ye C , TaoR , CaoQet al. Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma . Int. J. Oncol.49 ( 2 ), 589 – 602 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Hon GC , SongCX , DuTet al. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation . Mol. Cell56 ( 2 ), 286 – 297 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ono R , TakiT , TaketaniT , TaniwakiM , KobayashiH , HayashiY . LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23) . Cancer Res.62 ( 14 ), 4075 – 4080 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Forloni M , GuptaR , NagarajanAet al. Oncogenic EGFR represses the TET1 DNA demethylase to induce silencing of tumor suppressors in cancer cells . Cell Rep.16 ( 2 ), 457 – 471 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Li L , LiC , MaoHet al. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers . Sci. Rep.6 , 26591 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Pei YF , TaoR , LiJFet al. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression . Oncotarget7 ( 21 ), 31322 – 31335 ( 2016 ).
   PubMedGoogle Scholar
• Kroeze LI , Van Der ReijdenBA , JansenJH . 5-hydroxymethylcytosine: an epigenetic mark frequently deregulated in cancer . Biochim. Biophys. Acta1855 ( 2 ), 144 – 154 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pei YF , LeiY , LiuXQ . MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1 . Biochim. Biophys. Acta11 ( 10 ), 16 ( 2016 ).
   Google Scholar
• Wu MZ , ChenSF , NiehSet al. Hypoxia drives breast tumor malignancy through a TET–TNFalpha–p38–MAPK signaling axis . Cancer Res.75 ( 18 ), 3912 – 3924 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sang Y , ChengC , TangXF , ZhangMF , LvXB . Hypermethylation of TET1 promoter is a new diagnosic marker for breast cancer metastasis . Asian Pac. J. Cancer Prev.16 ( 3 ), 1197 – 1200 ( 2015 ).
   PubMedGoogle Scholar
• Letouze E , MartinelliC , LoriotCet al. SDH mutations establish a hypermethylator phenotype in paraganglioma . Cancer Cell23 ( 6 ), 739 – 752 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Oermann EK , WuJ , GuanKL , XiongY . Alterations of metabolic genes and metabolites in cancer . Semin. Cell Dev. Biol.23 ( 4 ), 370 – 380 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Toro JR , NickersonML , WeiMHet al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America . Am. J. Hum. Genet.73 ( 1 ), 95 – 106 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Yin R , MaoSQ , ZhaoBet al. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals . J. Am. Chem. Soc.135 ( 28 ), 10396 – 10403 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nestor CE , OttavianoR , ReinhardtDet al. Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems . Genome Biol.16 ( 1 ), 11 ( 2015 ).
   PubMedGoogle Scholar
• Baylin SB , HoppenerJW , De BustrosA , SteenberghPH , LipsCJ , NelkinBD . DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas . Cancer Res.46 ( 6 ), 2917 – 2922 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Cimmino L , DawlatyMM , Ndiaye-LobryDet al. TET1 is a tumor suppressor of hematopoietic malignancy . Nat. Immunol.16 ( 6 ), 653 – 662 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Struhl K . Is DNA methylation of tumour suppressor genes epigenetic?Elife3 , e02475 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gu J , StevensM , XingXet al. Mapping of variable DNA methylation across multiple cell types defines a dynamic regulatory landscape of the human genome . G3 (Bethesda)6 ( 4 ), 973 – 986 ( 2016 ).
   PubMedGoogle Scholar
• Chiappinelli KB , StrisselPL , DesrichardAet al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses . Cell162 ( 5 ), 974 – 986 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Roulois D , Loo YauH , SinghaniaRet al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts . Cell162 ( 5 ), 961 – 973 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Booth MJ , OstTW , BeraldiDet al. Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine . Nat. Protoc.8 ( 10 ), 1841 – 1851 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yu M , HonGC , SzulwachKEet al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome . Cell149 ( 6 ), 1368 – 1380 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Thomson JP , MoggsJG , WolfCR , MeehanRR . Epigenetic profiles as defined signatures of xenobiotic exposure . Mutat. Res.764–765 , 3 – 9 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Thomson JP , HunterJM , LempiainenHet al. Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver . Nucleic Acids Res.41 ( 11 ), 5639 – 5654 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Thomson JP , LempiainenH , HackettJAet al. Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome . Genome Biol.13 ( 10 ), R93 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lian CG , XuS , GuoWet al. Decrease of 5-hydroxymethylcytosine in rat liver with subchronic exposure to genotoxic carcinogens riddelliine and aristolochic acid . Mol. Carcinog.54 ( 11 ), 1503 – 1507 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gurbuz I , Chiquet-EhrismannR . CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer . Int. J. Biochem. Cell. Biol.62 , 142 – 146 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lempiainen H , CouttetP , BolognaniFet al. Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion . Toxicol. Sci.131 ( 2 ), 375 – 386 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gustafson CB , YangC , DicksonKMet al. Epigenetic reprogramming of melanoma cells by vitamin C treatment . Clin. Epigenetics7 ( 1 ), 51 ( 2015 ).
   PubMedGoogle Scholar
• Strand SH , HoyerS , LynnerupASet al. High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer . Clin. Epigenetics7 , 111 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang F , LiuY , ZhangZet al. 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas . Sci. Rep.6 , 20882 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Yang Q , WuK , JiMet al. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients . J. Biomed. Nanotechnol.9 ( 9 ), 1607 – 1616 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sproul D , NestorC , CulleyJet al. Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer . Proc. Natl Acad. Sci. USA108 ( 11 ), 4364 – 4369 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Moarii M , ReyalF , VertJP . Integrative DNA methylation and gene expression analysis to assess the universality of the CpG island methylator phenotype . Hum. Genomics9 , 26 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Gustafsson M et al. Modules, networks and systems medicine for understanding disease and aiding diagnosis . Genome Med.6 , 82 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Amabile A , MigliaraA , CapassoPet al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing . Cell167 ( 1 ), 219 – 232 ( 2016 ).
   PubMed Web of Science ®Google Scholar